Bilcare GCS Opens New Global U.S. Headquarters
Bilcare Global Clinical Supplies, a single-source provider of clinical trial services, announced that ithas opened its new global U.S. headquarters in San Francisco.
Bilcare GCS Opens New Global U.S. Headquarters
San Francisco, CA – July 31, 2008 - Bilcare Global Clinical Supplies, a
leading single-source provider of clinical trial services, announced that it
has opened its new global U.S. headquarters in San Francisco. The
headquarters, which will be led by CEO Vito Mangiardi, operates as the
company’s corporate hub to drive growth in Bilcare’s American, European, and
Asian regions.
“This year has been one of substantial growth in every area of our global
business, from staffing and facilities to equipment and services,” said
Mangiardi. “While our U.S., India, and Wales-based facilities manage the
increased demand for research and packaging services, our headquarters will
dedicate itself to furthering global integration and growing the company as
a full-service solutions provider that can take customers from research and
development, to Phase I and II trials, and through longer-term Phase III
trials.”
The opening of Bilcare GCS’ global headquarters marks the latest development
in the company’s significant growth. During its 2007-2008 fiscal year,
Bilcare GCS nearly doubled its global workforce, including significant
additions to its executive team; completed a US$2.3 million capital
investment program in the U.S.; expanded its facility in Rajgurunagar, near
Pune, India; plans US$21 million towards a new clinical supplies facility in
South Wales; and made significant global investments in technology, project
management, and quality standards to help drive customer satisfaction and
success. Other investments include new integrated business processes that
span the entire clinical supply chain and cutting-edge technology solutions
including interactive voice response/interactive web response (IVR/IWR)
services.
“Bilcare has built its reputation on providing customers with the
highest-quality clinical supplies and research services, delivered on time,
every time,” said Mangiardi. “Our new headquarters will allow us to take
our services to the next level while continuing to provide the quality and
attention that customers expect and deserve.”
About Bilcare Global Clinical Supplies
Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with
clinical trial materials support, services, and complete project management.
Its services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical
trial materials (CTM) satisfy a broad range of requirements; from
pre-formulation research and development, manufacturing, analytical services
and clinical supplies packaging and labeling, to IVRS, QP services,
controlled temperature (cold and frozen chain) CTM storage, distribution
worldwide, and returns and destructions accountability.
For more information about Bilcare Global Clinical Supplies, visit
www.BilcareGCS.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
